Nature Communications (Mar 2023)

Time-of-day defines NAD+ efficacy to treat diet-induced metabolic disease by synchronizing the hepatic clock in mice

  • Quetzalcoatl Escalante-Covarrubias,
  • Lucía Mendoza-Viveros,
  • Mirna González-Suárez,
  • Román Sitten-Olea,
  • Laura A. Velázquez-Villegas,
  • Fernando Becerril-Pérez,
  • Ignacio Pacheco-Bernal,
  • Erick Carreño-Vázquez,
  • Paola Mass-Sánchez,
  • Marcia Bustamante-Zepeda,
  • Ricardo Orozco-Solís,
  • Lorena Aguilar-Arnal

DOI
https://doi.org/10.1038/s41467-023-37286-2
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 24

Abstract

Read online

The timing of NAD + supply determines its efficacy to treat metabolic disease. Here, the authors show that increasing NAD + at the early active phase maximizes weight loss and glucose regulation in mice. NAD + can displace the phase of the liver clock which can cause circadian misalignment.